PCSK9 Inhibitors: What to Know if They Come to Market

By fall, there may be two new drugs in the lipid-lowering toolbox. Seth Bilazarian quizzes Marc Sabatine about what this means for the lipid landscape and the use of a genetic risk score.
Source: Medscape Cardiology Podcast - Category: Cardiology Authors: Source Type: podcasts